BGM [BGM] vs Zoetis [ZTS] Detailed Stock Comparison
BGM
NASDAQ
Loading...
Zoetis
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: BGM wins in 6 metrics, Zoetis wins in 10 metrics, with 0 ties. Zoetis appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | BGM | Zoetis | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 15.00 | 25.16 | BGM |
| Price-to-Book Ratio | 5.16 | 13.06 | BGM |
| Debt-to-Equity Ratio | 0.22 | 137.01 | BGM |
| PEG Ratio | N/A | 1.44 | N/A |
| EV/EBITDA | -29.15 | 17.80 | BGM |
| Profit Margin (TTM) | -26.32% | 27.83% | Zoetis |
| Operating Margin (TTM) | -5.41% | 40.20% | Zoetis |
| EBITDA Margin (TTM) | N/A | 40.20% | N/A |
| Return on Equity | -16.52% | 52.77% | Zoetis |
| Return on Assets (TTM) | -3.84% | 15.37% | Zoetis |
| Free Cash Flow (TTM) | $-3.39M | $2.30B | Zoetis |
| Dividend Yield | N/A | 1.11% | N/A |
| 1-Year Return | 37.88% | -22.95% | BGM |
| Price-to-Sales Ratio (TTM) | 64.28 | 6.91 | Zoetis |
| Enterprise Value | $69.18M | $70.26B | Zoetis |
| EV/Revenue Ratio | 2.32 | 7.49 | BGM |
| Gross Profit Margin (TTM) | N/A | 73.62% | N/A |
| Revenue per Share (TTM) | $4 | $21 | Zoetis |
| Earnings per Share (Diluted) | $-0.29 | $5.82 | Zoetis |
| Beta (Stock Volatility) | 1.46 | 0.90 | Zoetis |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
BGM vs Zoetis Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| BGM | 3.50% | 3.02% | 35.06% | -1.00% | -6.78% | 10.74% |
| Zoetis | 1.51% | 2.03% | -3.94% | -8.02% | -8.26% | -9.96% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| BGM | 37.88% | 58.40% | -77.37% | -77.37% | -77.37% | -77.37% |
| Zoetis | -22.95% | -0.64% | -11.49% | 242.10% | 372.17% | 372.17% |
News Based Sentiment: BGM vs Zoetis
BGM
News based Sentiment: MIXED
BGM Group is undergoing a major strategic shift, and while investor interest is high, there are conflicting signals regarding its valuation and technical outlook. The 35% stock surge is countered by a 49% predicted value decrease and bearish technical indicators, making this a significant but uncertain month for the company.
Zoetis
News based Sentiment: MIXED
The month featured both positive developments – the CVMP opinion for Portela® and generally positive analyst estimates – alongside negative signals like stock decline, technical warnings, and mixed institutional activity. This creates a balanced, rather than decisively positive or negative, investment narrative.
Performance & Financial Health Analysis: BGM vs Zoetis
| Metric | BGM | ZTS |
|---|---|---|
| Market Information | ||
| Market Cap | $1.91B | $65.09B |
| Market Cap Category | Small cap | Large cap |
| 10 Day Avg. Volume | 36,130 | 3,169,830 |
| 90 Day Avg. Volume | 50,380 | 2,720,843 |
| Last Close | $9.90 | $167.10 |
| 52 Week Range | $6.22 - $17.17 | $139.70 - $200.33 |
| % from 52W High | -42.31% | -16.59% |
| All-Time High | $110.00 (Jan 11, 2021) | $249.27 (Dec 27, 2021) |
| % from All-Time High | -91.00% | -32.96% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.57% | 0.04% |
| Quarterly Earnings Growth | -0.16% | 0.15% |
| Financial Health | ||
| Profit Margin (TTM) | -0.26% | 0.28% |
| Operating Margin (TTM) | -0.05% | 0.40% |
| Return on Equity (TTM) | -0.17% | 0.53% |
| Debt to Equity (MRQ) | 0.22 | 137.01 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $1.85 | $11.21 |
| Cash per Share (MRQ) | $3.55 | $3.28 |
| Operating Cash Flow (TTM) | $2.96M | $2.93B |
| Levered Free Cash Flow (TTM) | $3.36M | $2.29B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 1.11% |
| Last 12-Month Dividend | $0.00 | $1.86 |
Valuation & Enterprise Metrics Analysis: BGM vs Zoetis
| Metric | BGM | ZTS |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 15.00 | 25.16 |
| Forward P/E | N/A | 23.09 |
| PEG Ratio | N/A | 1.44 |
| Price to Sales (TTM) | 64.28 | 6.91 |
| Price to Book (MRQ) | 5.16 | 13.06 |
| Market Capitalization | ||
| Market Capitalization | $1.91B | $65.09B |
| Enterprise Value | $69.18M | $70.26B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 2.32 | 7.49 |
| Enterprise to EBITDA | -29.15 | 17.80 |
| Risk & Other Metrics | ||
| Beta | 1.46 | 0.90 |
| Book Value per Share (MRQ) | $1.85 | $11.21 |
Financial Statements Comparison: BGM vs Zoetis
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | BGM | ZTS |
|---|---|---|
| Revenue/Sales | N/A | $2.22B |
| Cost of Goods Sold | N/A | $622.00M |
| Gross Profit | N/A | $1.60B |
| Research & Development | N/A | $157.00M |
| Operating Income (EBIT) | N/A | $846.00M |
| EBITDA | N/A | $991.00M |
| Pre-Tax Income | N/A | $810.00M |
| Income Tax | N/A | $179.00M |
| Net Income (Profit) | N/A | $631.00M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | BGM | ZTS |
|---|---|---|
| Cash & Equivalents | $9.65M | $1.72B |
| Total Current Assets | $42.94M | $5.88B |
| Total Current Liabilities | $23.59M | $3.39B |
| Long-Term Debt | $78,759 | $5.40B |
| Total Shareholders Equity | $183.49M | $4.66B |
| Retained Earnings | $3.49M | $12.38B |
| Property, Plant & Equipment | $0 | $6.36B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | BGM | ZTS |
|---|---|---|
| Operating Cash Flow | N/A | $567.00M |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | $438.00M |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | $-443.00M |
Short Interest & Institutional Ownership Analysis
| Metric | BGM | ZTS |
|---|---|---|
| Shares Short | 7,202 | 9.19M |
| Short Ratio | 0.17 | 3.71 |
| Short % of Float | 0.00% | 0.02% |
| Average Daily Volume (10 Day) | 36,130 | 3,169,830 |
| Average Daily Volume (90 Day) | 50,380 | 2,720,843 |
| Shares Outstanding | 7.23M | 448.47M |
| Float Shares | 2.83M | 442.31M |
| % Held by Insiders | 0.07% | 0.00% |
| % Held by Institutions | 0.00% | 0.99% |
Dividend Analysis & Yield Comparison: BGM vs Zoetis
| Metric | BGM | ZTS |
|---|---|---|
| Last 12-Month Dividend | $0.00 | $1.86 |
| Last 12-Month Dividend Yield | N/A | 1.11% |
| 3-Year Avg Annual Dividend | $0.08 | $1.63 |
| 3-Year Avg Dividend Yield | 3.70% | 0.24% |
| 3-Year Total Dividends | $0.25 | $4.90 |
| Ex-Dividend Date | Feb 27, 2023 | Apr 21, 2025 |